Trials / Conditions / Hyperlipoproteinemia Type II

Hyperlipoproteinemia Type II

8 registered clinical trials studyying Hyperlipoproteinemia Type II.

Status	Trial	Sponsor	Phase
Completed	FH Detection in Children by Salivary Test NCT04261803	Hospices Civils de Lyon	—
Completed	Safety Study of AEM-28 to Treat Refractory Hypercholesterolemia NCT02100839	LipimetiX Development, LLC	Phase 1 / Phase 2
Terminated	Efficacy and Tolerability of Anacetrapib Added to Ongoing Lipid-Lowering Therapy in Adult Participants With Ho NCT01841684	Merck Sharp & Dohme LLC	Phase 3
Completed	Study to Assess the Tolerability and Efficacy of Anacetrapib (MK-0859) Co-Administered With Statin in Particip NCT01524289	Merck Sharp & Dohme LLC	Phase 3
Completed	An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patie NCT00694109	Kastle Therapeutics, LLC	Phase 3
Completed	Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemi NCT00607373	Kastle Therapeutics, LLC	Phase 3
Completed	Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia NCT00477594	Kastle Therapeutics, LLC	Phase 2
Completed	Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANC NCT00552097	Organon and Co	Phase 3